Clinuvel Pharmaceuticals Stock Quote CUV - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

14.85

Bid

20.72

Ask

14.06

Volume

0.00

0.00 Day's Range 0.00

12.96 52 Week Range 18.20

Market Cap

744.041M

Previous Close

14.85

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

81,245

Shares Outstanding

50,103,765

Dividend Yield

PE Ratio

20.88

Earnings Per Share (EPS)

0.71

Revenue

88.74M

Net Profit

35.64M

Sector

Medicinal Chems,botanicl Pds

Industry

Drugs-health R&d/testing Labs

Website

www.clinuvel.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD14.85. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 12.96 to AUD 18.20.

Clinuvel Pharmaceuticals currently has 50,103,765 shares outstanding. The market capitalization of Clinuvel Pharmaceuticals is AUD744.04 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 20.88.

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA...

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class...

Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise on the interaction of light and human skin...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-0.66889632107	14.95	15.99	14.61	81255	15.2827337	DE
4	1.39	10.3268945022	13.46	15.99	13.13	92471	14.84055338	DE
12	-0.53	-3.44603381014	15.38	17.71	13.13	81245	14.93680486	DE
26	0.83	5.92011412268	14.02	17.71	13.13	88384	15.02494344	DE
52	-1.32	-8.16326530612	16.17	18.2	12.96	91455	15.21246073	DE
156	-26.65	-64.2168674699	41.5	44.67	12.96	103396	20.0272799	DE
260	-11.15	-42.8846153846	26	45.88	12.92	132112	23.03822199	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1ADAdAlta Limited	AUD 0.019 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.07 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
1ADAdAlta Limited	AUD 0.019 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.07 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
WNXWellnex Life Ltd	AUD 0.02 (0.00%)	21M
TAHTabcorp Holdings Limited	AUD 1.26 (0.00%)	11.5M
AW1American West Metals Ltd	AUD 0.10 (0.00%)	5.18M
FMGFortescue Ltd	AUD 30.01 (0.00%)	4.79M
PLSPilbara Minerals Limited	AUD 5.51 (0.00%)	4.68M